Botanical species · safety record

Clematis montana

The EFSA Compendium of Botanicals holds 3 constituent measurements for Clematis montana. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Clematis montana Buch.-Ham. ex DC.

3Constituent measurements

0Safety records

3Cited sources

1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Clematis montana as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Stem(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Lectins	Stem / stalk	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Saponins	—	—	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Clemontanosides	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Thapliyal, R. P., Bahuguna, R. P. Clemontanoside-E, a new saponin from Clematis montana. International Journal of Pharmacognosy, 1994, vol. 32, no. 4, p. 373-377.
Peng, Hao., Lv, Hui., Wang, Ying., Liu, Yan-hong., Lia, Chun-yang., Meng, Liang., Chen, Fang., Bao, Jin-ku. Clematis montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities. PEPTIDES, 2009, vol. 30, no. 10, p. 1805-1815. DOI
Bahuguna, R.P., Thapliyal, R.P., Murakami, N., Tanase, T., Kaiya, T., Sakakibara, J. Saponins from clematis Montana. Pharmaceutical biology, 1990, vol. 28, no. 2, p. 125-127. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature